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Evolution is frequently considered as a
directional process in which the organ-
isms do not return, after evolving, to
a pre-evolved situation. However, there
are occassions in which evolution follows
a sort of cycling process. Each time an
organism is confronted with a given selec-
tive situation, it follows a similar evolution
path. However, once the selection pressure
is resumed, the organism is outcompeted
by non-evolved partners and the evolved
lineage disappears. This type of process has
been dubbed as “short sighted evolution”
(Levin and Bull, 1994) and is fundamen-
tal for understanding the in host adapta-
tion processes of bacterial opportunistic
pathogens.
Opportunistic pathogens are a group
of microorganisms that do not usu-
ally infect healthy hosts but produce
infections in hospitals, to immunode-
pressed persons or those patients present-
ing underlying diseases as cystic fibrosis,
which favors infection (Koch and Hoiby,
1993). Commensal bacteria are among the
most prevalent opportunistic pathogens.
However, the use of antibiotics, which usu-
ally kill commensals besides pathogens,
increased the incidence of infections due
to environmental microorganisms pre-
senting reduced susceptibility to antibi-
otics (Bergogne-Berezin et al., 1993).
The evolution of non-pathogenic bac-
teria towards virulence has been deci-
phered in occasions. Many “professional”
pathogens harbor different sets of genes,
dubbed as pathogenicity islands, which
have been acquired by horizontal gene
transfer, and allow such pathogens to
infect the human host (Groisman and
Ochman, 1996; Morschhauser et al., 2000;
Gal-Mor and Finlay, 2006). The best stud-
ied among these evolution processes is
that of Yersinia pestis, the causal agent
of plague (Achtman et al., 2004; Zhou
and Yang, 2009). The genus Yersinia is
formed by 15 different species among
which only Y. pestis, Yersinia pseudotu-
berculosis, and Yersinia enterocolitica are
human pathogens. Phylogenetic recon-
struction of the evolution of this genus
indicates that Y. pseudotuberculosis and Y.
enterocolitica diverged more than 40 mil-
lion years ago, while Y. pestis diverged from
Y. pseudotuberculosis less than 20,000 years
ago (Achtman et al., 1999). The ancestor of
these pathogenic Yersiniae evolved towards
virulence, from a non-pathogenic environ-
mental Yersiniae, by acquiring a virulence
plasmid named pCD1 (Wren, 2003). This
plasmid contains genes coding for a Type
III secretion system, which activity allows
subversion of the immune system, and is
required for the virulence of this pathogen.
It is worth mentioning that the acquisition
of this plasmid occurred before the diver-
gence between Y. pseudotuberculosis and
Y. enterocolitica, hence more than 40 mil-
lion years ago; long before the origin of
the genus Homo (Wood, 1992; McHenry,
1994). This means that the evolution of
human pathogens is not exclusively driven
by the infection of humans (Martinez,
2013). As stated before, the speciation of Y.
pestis from Y. pseudotuberculosis is a much
more recent process that involves both the
acquisition of some genes and the loss of
other ones. The loss of genes has been
frequently associated to genome reduction
evolution mostly in the case of endosym-
bionts (Perez-Brocal et al., 2006). For
these microorganisms, several metabolic
functions can be covered by the host and
un-needed genes are lost just by gene drift.
The situation concerning Yersinia is not
the same. In its process of evolution Y.
pestis had lost a set of genes encoding
insect toxins. Consequently, the evolved
organism does not kill insects, a property
that allowed its improved transmission by
beats of colonized insects (Chouikha and
Hinnebusch, 2012). Since this may mean
that Y. pestis is in the process of evolution
toward commensalism in insects, we may
conclude that a relevant element for the
success of Y. pestis as a human pathogen
comes from its adaptation to a completely
different host, in this case the insects.
As described in this example, evolu-
tion towards virulence involves the acqui-
sition of some elements and the loss of
other ones. This process leads to specia-
tion from non-virulent towards virulent
microorganisms. Whilst this is the situa-
tion for several “professional” pathogens,
the evolution process of opportunistic bac-
terial pathogens is rather different. As
above stated, these organisms do not infect
healthy people and the main factor allow-
ing infection is the patient predisposition
for being infected. This may mean that any
organism may infect an immunocompro-
mised patient, something that is not fully
true.
The human body can be considered as
an extreme environment. Actually, when
we talk about human microbiota we refer
to microorganisms colonizing the surfaces
of human body; the body itself is an sterile
environment unless an infection occurs.
The entrance in this ecosystems requires
either the acquisition of virulence determi-
nants to cope with the human defences, as
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happens with the aforementioned example
of Y. pestis, either a decay in these defences,
as occurs for opportunistic pathogens.
However, even in this last case, to colonize
the human host a microorganism requires
to survive under the physicochemical con-
ditions of human body: a narrow range
of temperature oxygen tension and pH;
some specific nutrients and low iron
availability. In the case of opportunistic
pathogens infecting immunocompetent
patients as those suffering cystic fibrosis,
mechanisms to cope with the immune
response are also needed. In addition, and
since patients at hospitals are frequently
under antibiotic therapy, these oppor-
tunistic pathogens frequently display low
susceptibility to antibiotics (Martinez and
Baquero, 2002). Indeed, antibiotic treat-
ment is a risk factor for being infected
by some environmental opportunistic
pathogens presenting low susceptibil-
ity to antibiotics as Stenotrophomonas
maltophilia (Alonso and Martinez, 1997;
Sanchez et al., 2009).
One of the best studied bacterial oppor-
tunistic pathogens is Pseudomonas aerug-
inosa. This microorganism is currently
among the most prevalent causes of infec-
tion at hospitals and is the major cause
of chronic infections in cystic fibrosis
patients. These patients are frequently
infected by a single P. aeruginosa clone that
remains and evolves in the lung of the
patient for decades (Yang et al., 2011).
Since P. aeruginosa is an environmental
bacterium, it might be thought that vir-
ulent strains constitute a specific branch
in the species, which is in its route to
speciation as it has happened with “profes-
sional” pathogens. Nevertheless, molecu-
lar epidemiology has shown that the same
clonal complexes present in non-clinical
ecosystems are the ones producing infec-
tions (Morales et al., 2004; Wiehlmann
et al., 2007; Kidd et al., 2012). Further,
the comparison of clinical and non-clinical
isolates showed that they were function-
ally equivalent. All of them extruded
the synthetic antibiotics quinolones, pre-
sented the genes encoding the elements
of the Type III secretion system and of
the quorum sensing regulation response
and were capable to invade epithelial cells;
all these characteristics typical of viru-
lent strains. In addition, all strains were
able of use oil hydrocarbons as carbon
sources, a feature characteristic of environ-
mental biodegradative microorganisms,
which is not required for producing an
infection (Alonso et al., 1999). Together
with the aforementioned epidemiological
evidences, this indicates that P. aerugi-
nosa does not present two evolutionary
branches, one of them towards virulence.
Rather, several if not all of the strains
have the capability of infecting patients
presenting underlying diseases. The rea-
son for this situation resides likely in
the ability of P. aeruginosa for infecting
several different hosts besides humans,
including plants, protozoans, worms or
insects (Rahme et al., 1995; Tan et al.,
1999; Mahajan-Miklos et al., 2000; Navas
et al., 2007; Broderick et al., 2008; Carilla-
Latorre et al., 2008). Since the same viru-
lence determinants serve to infect all these
host it is worth thinking that such determi-
nants evolved during the interaction with
the oldest organisms in this phylogenetic
tree. In this respect, it is worth mention-
ing that P. aeruginosa is able to avoid being
killed by bacteriovorous nematodes and
protozoans (Mahajan-Miklos et al., 1999;
Cosson et al., 2002). It is then possible that
a major force in the evolution of P. aerug-
inosa (and by extension of other oppor-
tunistic pathogens with an environmen-
tal origin) resides in ancient prey/predator
relationships (Martinez, 2013).
All these studies reinforce the idea P.
aeruginosa did not evolve toward virulence
in humans. Rather, this bacterial species
can infect humans by using elements that
evolved for its interaction with other hosts
(Rahme et al., 1995;Mahajan-Miklos et al.,
2000). Nevertheless, once a strain enters
inside the human host, it can evolve to
improve its adaptation to this new envi-
ronment (Folkesson et al., 2012). Whereas
in the case of “professional” pathogens,
these changes are usually fixed and con-
tribute to speciation, the same does not
necessarily happen in the case of oppor-
tunistic pathogens. The evolution of P.
aeruginosa during chronic infections has
been studied in detail. It has been found
that strains producing chronic infection
carry mutations in global regulation fac-
tors that regulate expression of P. aerug-
inosa social cooperative traits, including
secretion of exo-products and quorum
sensing. As a consequence, expression of
these elements, which are of relevance in
P. aeruginosa acute infections, is reduced
in chronic strains (Martinez-Solano et al.,
2008; Damkiaer et al., 2013; Jiricny et al.,
2014). This in-host evolution process is
favored by the increased prevalence of
strains presenting high mutation rates
found in chronic infections (Oliver et al.,
2000; Mena et al., 2008).
It can be thought that these adaptive
mutations could be fixed in the popu-
lation, hence constituting the beginning
of a speciation process towards virulence.
However, with the exception of some epi-
demic clones causing infections in cystic
fibrosis patients, mainly at Denmark and
England (see below), most patients are
infected by independent P. aeruginosa iso-
lates (Bragonzi et al., 2009), which do not
present, during the first stages of infection,
the pathoadaptive mutations displayed by
the evolved chronic strains. This evolu-
tion process by which an organism fol-
lows the same pattern of evolution (that
is not fixed afterwards) each time it enters
in a given ecosystem has been dubbed as
short-sighted evolution (Levin and Bull,
1994). This process is likely fundamental
for the adaption of microorganisms pro-
ducing chronic infections with low inter-
patient transmission rates.
Although each bacterial isolate colo-
nizes the lung of an independent patient,
all lungs are quite similar habitats. It is
then expected that the evolutionary land-
scapes of each of this chronic strains
may be similar. However, once bacteria
are released, these adaptations are of no
use unless the microorganism colonize
another cystic fibrosis patient. This is likely
the situation of countries as Denmark in
which patients have been usually in con-
tact for treatment and in occasions even
on holiday camps (Ojeniyi et al., 2000).
Similarly, it has been shown that the acqui-
sition of novel prophage islands is a criti-
cal event in increasing the competitiveness
of epidemic P. aeruginosa clones as the
Liverpool strain (Winstanley et al., 2009).
It could be predicted that under those
circumstances epidemic clones, presenting
cystic fibrosis adaptive mutations spread,
a situation that has been already described
in occasions (Jelsbak et al., 2007; Rau et al.,
2010; Dettman et al., 2013). Whether or
not these epidemic clones are in the route
of speciation remains to be established.
However, the fact that the implementation
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of strict cohort-based patients segrega-
tion policy has halted the epidemic of
the Liverpool strain, with an increase in
the percentage of patients with unique P.
aeruginosa strains (Ashish et al., 2013),
indicates this adaptation to be still tran-
sient.
In other cases in which inter-host trans-
mission is low, the evolved isolates are
released into natural ecosystems. The loss
of elements that were fixed, long time ago,
during the evolution of P. aeruginosa in its
natural habitats, make these evolved clones
to be outcompeted by the bulk of the pop-
ulation. In this regard, it is worth men-
tioning that P. aeruginosa strains adapted
for growing in the lungs of cystic fibro-
sis patients present a decreased resistance
to natural phage and protists predators
(Friman et al., 2013).
Short-sighted evolution is a common
process in the evolution of microorgan-
isms and has been explained in the frame
of a source-sink situation (Sokurenko
et al., 2006). In the case of opportunis-
tic environmental pathogens, as P. aerug-
inosa, the majority of the population is
present at its original, non-clinical habi-
tat, which constitutes the source of this
species. Only a few of these microorgan-
isms infect some patients (sink), just by
chance. Evolution during chronic infec-
tion allows the adaptation required to per-
sist inside the infected host. However, this
happens at the cost of de-adapting for
growing in the original habitat, includ-
ing resistance to natural predators (Friman
et al., 2013). The only possibility for
the fixation of mutations acquired dur-
ing chronic infections is a high inter-host
transmission, in which case the adapted
strain can remain in a habitat (the lung
of a different host) that is similar to the
one where it evolved without affording
the costs of returning to its original non-
clinical habitat.
We can then conclude that while the
acquisition and loss of genes are at
the roots of the speciation of “profes-
sional” pathogens, speciation toward vir-
ulence is not necessarily required for
bacterial opportunistic pathogens. This
does not mean however these pathogens
do not evolve for a better adaptation
for growing in the human host. Indeed,
the study of P. aeruginosa shows that
there are common evolution patterns
among isolates producing chronic infec-
tions. Nevertheless, these mutations are
rarely fixed (with the exception of some
epidemic clones Yang et al., 2011, see
above); those strains infecting for the first
time a patient present in most cases the
characteristics of a wild-type strain, not
of the ones that evolved during chronic
infections. This process that has been
dubbed as short-sighted evolution because
the organism cannot “foresee” the conse-
quences of such evolution is fundamental
for the adaptation of environmental bacte-
rial opportunistic pathogens to the human
host.
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